othello®
bayer ag - olie dispersie - 50 g/l diflufenican 2,5 g/l iodosulfuron-methyl-natrium 7,5 g/l mesosulfuron-methyl
sencor® vloeibaar
bayer ag - suspensie concentraat - 600 g/l metribuzin
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastische middelen - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastische middelen - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
zynlonta
swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastische middelen - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.
prelexa 100 mg harde capsules
maddox pharma swiss b.v. wilhelminapark 17 2342 ad oegstgeest - pregabaline 100 mg/stuk - capsule, hard - ammonia (e 527) ; gelatine (e 441) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; mannitol (d-) (e 421) ; maÏszetmeel ; maÏszetmeel, gepregelatineerd ; propyleenglycol (e 1520) ; schellak (e 904) ; talk (e 553 b) ; titaandioxide (e 171) ; zwarte inkt
prelexa 150 mg harde capsules
maddox pharma swiss b.v. wilhelminapark 17 2342 ad oegstgeest - pregabaline 150 mg/stuk - capsule, hard - ammonia (e 527) ; gelatine (e 441) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; mannitol (d-) (e 421) ; maÏszetmeel ; maÏszetmeel, gepregelatineerd ; propyleenglycol (e 1520) ; schellak (e 904) ; talk (e 553 b) ; titaandioxide (e 171) ; zwarte inkt
prelexa 200 mg harde capsules
maddox pharma swiss b.v. wilhelminapark 17 2342 ad oegstgeest - pregabaline 200 mg/stuk - capsule, hard - ammonia (e 527) ; gelatine (e 441) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; mannitol (d-) (e 421) ; maÏszetmeel ; maÏszetmeel, gepregelatineerd ; propyleenglycol (e 1520) ; schellak (e 904) ; talk (e 553 b) ; titaandioxide (e 171) ; zwarte inkt
prelexa 225 mg harde capsules
maddox pharma swiss b.v. wilhelminapark 17 2342 ad oegstgeest - pregabaline 225 mg/stuk - capsule, hard - ammonia (e 527) ; gelatine (e 441) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; mannitol (d-) (e 421) ; maÏszetmeel ; maÏszetmeel, gepregelatineerd ; propyleenglycol (e 1520) ; schellak (e 904) ; talk (e 553 b) ; titaandioxide (e 171) ; zwarte inkt
prelexa 25 mg harde capsules
maddox pharma swiss b.v. wilhelminapark 17 2342 ad oegstgeest - pregabaline 25 mg/stuk - capsule, hard - ammonia (e 527) ; gelatine (e 441) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; mannitol (d-) (e 421) ; maÏszetmeel ; maÏszetmeel, gepregelatineerd ; propyleenglycol (e 1520) ; schellak (e 904) ; talk (e 553 b) ; titaandioxide (e 171) ; zwarte inkt